Skip to primary navigation Skip to main content
0 item $0.00

  1. Abbott AL. Current medical intervention alone is now the best solution for asymptomatic carotid stenosis. Letter to the editors of Journal of Vascular Surgery and the European Journal of Vascular and Endovascular Surgery regarding trans-atlantic debate no. 1. Eur J Vasc Endovasc Surg 2010;40(5):678-9. Letter.
  2. Abraham G, Kowalczyk A, Loi S, Haviv I, Zobel J. Prediction of breast cancer prognosis using gene set statistics provides signature stability and biological context. BMC Bioinformatics 2010;11(1):277.
  3. Ahola AJ, Mäkimattila S, Saraheimo M, Mikkilä V, Forsblom C, Freese R, Groop PH; FinnDIANE Study Group. Many patients with Type 1 diabetes estimate their prandial insulin need inappropriately. J Diabetes 2010;2(3):194-202.
  4. Ahrens I, Lip GY, Peter K. New oral anticoagulant drugs in cardiovascular disease. Thromb Haemost 2010;104(1):49-60. Review.
  5. Allen TL, Febbraio MA. IL6 as a mediator of insulin resistance: fat or fiction? Diabetologia 2010;53(3):399-402. Review.
  6. Altmann DR, Korte W, Maeder MT, Fehr T, Haager P, Rickli H, Kleger GR, Rodriguez R, Ammann P. Elevated cardiac troponin I in sepsis and septic shock: no evidence for thrombus associated myocardial necrosis. PLoS One 2010;5(2):e9017.
  7. Amar MJ, D'Souza W, Turner S, Demosky S, Sviridov D, Stonik J, Luchoomun J, Voogt J, Hellerstein M, Sviridov D, Remaley AT. 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice. J Pharmacol Exp Ther 2010;334(2):634-41.
  8. Andrews KL, Moore XL, Chin-Dusting JP. Anti-atherogenic effects of high-density lipoprotein on nitric oxide synthesis in the endothelium. Clin Exp Pharmacol Physiol 2010;37(7):736-42. Review.
  9. Anstey KJ, Byles JE, Luszcz MA, Mitchell P, Steel D, Booth H, Browning C, Butterworth P, Cumming RG, Healy J, Windsor TD, Ross L, Bartsch L, Burns RA, Kiely K, Birrell CL, Broe GA, Shaw J, Kendig H. Cohort profile: the dynamic analyses to optimize ageing (DYNOPTA) project. Int J Epidemiol 2010;39(1):44-51.
  10. Aschner P, Horton E, Leiter LA, Munro N, Skyler JS; Global Partnership for Effective Diabetes Management. Practical steps to improving the management of Type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management. Int J Clin Pract 2010;64(3):305-15.
  11. Astrup A, Clifton P, Layman DK, Mattes RD, Westerterp-Plantenga M. Meat intake's influence on body fatness cannot be assessed without measurement of body fat. Am J Clin Nutr 2010;92(5):1274-5. Letter.
  12. Asztalos BF, Mujawar Z, Morrow MP, Grant A, Pushkarsky T, Wanke C, Shannon R, Geyer M, Kirchhoff F, Sviridov D, Fitzgerald ML, Bukrinsky M, Mansfield KG. Circulating Nef induces dyslipidemia in simian immunodeficiency virus-infected macaques by suppressing cholesterol efflux. J Infect Dis 2010;202(4):614-23.
  13. Atkins RC, Zimmet P; 2010 International Society of Nephrology/International Federation of Kidney Foundations World Kidney Day Steering Committee; International Diabetes Federation. Diabetic kidney disease: act now or pay later. Acta Diabetol; Acta Physiol Hung; Am J Kidney Dis; Am J Med Sci; Am J Nephrol; Arch Cardiol Mex; Arch Iran Med; Blood Purif; Clin Nephrol; Diabetes Res Clin Pract; Iran J Kidney Dis; J Am Soc Hypertens; J Hypertens; J Nephrol, Kidney Blood Press Res, Kidney Int, Med J Aust, Nat Rev Nephrol, Nephrology, Nephron Clin Pract, Pediatr Nephrol, Saudi J Kidney Dis Transpl, Ther Apher Dial. 2010. Editorial published in many journals.
  14. Azarpazhooh MR, Etemadi MM, Donnan GA, Mokhber N, Majdi MR, Ghayour-Mobarhan M, Ghandehary K, Farzadfard MT, Kiani R, Panahandeh M, Thrift AG. Excessive incidence of stroke in Iran. Evidence from the Mashhad Stroke Incidence Study (MSIS), a population-based study of stroke in the Middle East. Stroke 2010;41(1):e3-e10.
  15. Baker EK, El-Osta A. Epigenetic regulation of multidrug resistance 1 gene expression: profiling CpG methylation status using bisulphite sequencing. Methods Mol Biol 2010;596:183-98.
  16. Balcerczyk A, Pirola L. Therapeutic potential of activators and inhibitors of sirtuins. Biofactors 2010;36(5):383-93. Review.
  17. Ballinger ML, Osman N, Hashimura K, de Haan JB, Jandeleit-Dahm K, Allen T, Tannock LR, Rutledge JC, Little PJ. Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo. J Cell Mol Med 2010;14(6B):1408-18.
  18. Barlovic DP, Thomas MC, Jandeleit-Dahm K. Cardiovascular disease: what's all the AGE/RAGE about? Cardiovasc Hematol Disord Drug Targets 2010;10(1):7-15. Review.
  19. Barr EL, Cameron AJ, Balkau B, Zimmet PZ, Welborn TA, Tonkin AM, Shaw JE. HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia 2010;53(1):79-88.
  20. Baumert M, Lambert E, Vaddadi G, Sari CI, Esler M, Lambert G, Sanders P, Nalivaiko E. Cardiac repolarization variability in patients with postural tachycardia syndrome during graded head-up tilt. Clin Neurophysiol 2010;122(2):405-9.
  21. Bayles R, Baker E, Eikelis N, El-Osta A, Lambert G. Histone modifications regulate the norepinephrine transporter gene. Cell Cycle 2010;9(22):4600-1.
  22. Beauchamp AJ, Peeters A, Wolfe R, Turrell G, Harriss LR, Giles GG, English DR, McNeil J, Magliano D, Harrap S, Liew D, Hunt D, Tonkin AM. Inequalities in cardiovascular disease mortality: the role of behavioural, physiological and social risk factors. J Epidemiol Community Health 2010;64(6):542-8.
  23. Becker AC, Libhaber E, Sliwa K, Stewart S, Essop MR. Markers of inflammation and endothelial activation in black South Africans with HIV and acute coronary syndromes. J AIDS HIV Res 2010;2(6):104-10.
  24. Becker AC, Sliwa K, Stewart S, Libhaber E, Essop AR, Zambakides CA, Essop MR. Acute coronary syndromes in treatment-naïve black South Africans with human immunodeficiency virus infection. J Interv Cardiol 2010;23(1):70-7.
  25. Belobrajdic DP, Frystyk J, Jeyaratnaganthan N, Espelund U, Flyvbjerg A, Clifton PM, Noakes M. Moderate energy restriction-induced weight loss affects circulating IGF levels independent of dietary composition. Eur J Endocrinol 2010;162(6):1075-82.
  26. Benassi-Evans B, Clifton P, Noakes M, Fenech M. High-protein/high red meat and high-carbohydrate weight-loss diets do not differ in their effect on faecal water genotoxicity tested by use of the WIL2-NS cell line and with other biomarkers of bowel health. Mutat Res 2010;703(2):130-6.
  27. Bennie J, Timperio A, Dunstan D, Crawford D, Salmon J. Environmental correlates of physical activity in Australian workplaces. Int J Workplace Health Manag 2010;3(1):25-33.
  28. Bernardo BC, Weeks KL, Pretorius L, McMullen JR. Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther 2010;128(1):191-227.
  29. Berry PA, Maciewicz RA, Cicuttini FM, Jones MD, Hellawell CJ, Wluka AE. Markers of bone formation and resorption identify subgroups of patients with clinical knee osteoarthritis who have reduced rates of cartilage loss. J Rheumatol 2010;37(6):1252-9.
  30. Berry PA, Maciewicz RA, Wluka AE, Downey-Jones MD, Forbes A, Hellawell CJ, Cicuttini FM. Relationship of serum markers of cartilage metabolism to imaging and clinical outcome measures of knee joint structure. Ann Rheum Dis 2010;69(10):1816-22.
  31. Berry PA, Wluka AE, Davies-Tuck ML, Wang Y, Strauss BJ, Dixon JB, Proietto J, Jones G, Cicuttini FM. The relationship between body composition and structural changes at the knee. Rheumatology 2010;49(12):2362-9.
  32. Bobik A. Circulating microparticles. Markers or participants in carotid artery remodelling? J Hypertens 2010;28(4):673-5. Editorial.
  33. Böhm M, Baumhäkel M, Teo K, Sleight P, Probstfield J, Gao P, Mann JF, Diaz R, Dagenais GR, Jennings GL, Liu L, Jansky P, Yusuf S; ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators. Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials. Circulation 2010;121(12):1439-46.
  34. Boyko EJ, Gerstein HC, Mohan V, Yusuf S, Sheridan P, Anand S, Shaw JE; DREAM trial investigators. Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabet Med 2010;27(11):1226-32.
  35. Bozaoglu K, Curran JE, Stocker CJ, Zaibi MS, Segal D, Konstantopoulos N, Morrison S, Carless M, Dyer TD, Cole SA, Goring HH, Moses EK, Walder K, Cawthorne MA, Blangero J, Jowett JB. Chemerin, a novel adipokine in the regulation of angiogenesis. J Clin Endocrinol Metab 2010;95(5):2476-85.
  36. Brace RJ, Sorrenson B, Sviridov D, McCormick SP. A gel-based method for purification of apolipoprotein A-I from small volumes of plasma. J Lipid Res 2010;51(11):3370-6.
  37. Brennan SL, Pasco JA, Urquhart DM, Oldenburg B, Hanna FS, Wluka AE. The association between urban or rural locality and hip fracture in community-based adults: a systematic review. J Epidemiol Community Health 2010;64(8):656-65. Review.
  38. Brinkworth GD, Buckley JD, Noakes M, Clifton PM. Renal function following long-term weight loss in individuals with abdominal obesity on a very-low-carbohydrate diet vs high-carbohydrate diet. J Am Diet Assoc 2010;110(4):633-8.
  39. Brown A. Acute coronary syndromes in indigenous Australians: opportunities for improving outcomes across the continuum of care. Heart Lung Circ 2010;19(5-6):325-36.
  40. Brown A, Brieger D, Tonkin A, White H, Walsh W, Riddell T, Zeitz C, Jeremy R, Kritharides L. Coronary disease in indigenous populations: summary from the CSANZ indigenous Cardiovascular Health Conference. Heart Lung Circ 2010;19(5-6):299-305. Review.
  41. Brown A, Kritharides L. Cardiovascular disease. Heart Lung Circ 2010;19(5-6):263. Editorial.
  42. Buchert M, Athineos D, Abud HE, Burke ZD, Faux MC, Samuel MS, Jarnicki AG, Winbanks CE, Newton IP, Meniel VS, Suzuki H, Stacker SA, Näthke IS, Tosh D, Huelsken J, Clarke AR, Heath JK, Sansom OJ, Ernst M. Genetic dissection of differential signaling threshold requirements for the Wnt/-catenin pathway in vivo. PLoS Genet 2010;6(1):e1000816.
  43. Burch ML, Ballinger ML, Yang SN, Getachew R, Itman C, Loveland K, Osman N, Little PJ. Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor  type I receptor. J Biol Chem 2010;285(35):26798-805.
  44. Burch ML, Yang SN, Ballinger ML, Getachew R, Osman N, Little PJ. TGF-beta stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2. Cell Mol Life Sci 2010;67(12):2077-90.
  45. Burke SL, Evans RG, Head GA. Effects of chronic sympatho-inhibition on reflex control of renal blood flow and plasma renin activity in renovascular hypertension. Br J Pharmacol 2010;159(2):438-48.
  46. Burns WC, Thomas MC. Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease. Cells Tissues Organs 2010;193(1-2):74-84. Review.
  47. Burns WC, Thomas MC. The molecular mediators of type 2 epithelial to mesenchymal transition (EMT) and their role in renal pathophysiology. Expert Rev Mol Med 2010;12:e17.
  48. Burns WC, Velkoska E, Dean R, Burrell LM, Thomas MC. Angiotensin II mediates epithelial-to-mesenchymal transformation in tubular cells by ANG 1-7/MAS-1-dependent pathways. Am J Physiol Renal Physiol 2010;299(3):F585-93.
  49. Buyken AE, Flood V, Rochtchina E, Nestel P, Brand-Miller J, Mitchell P. Modifications in dietary fat quality are associated with changes in serum lipids of older adults independently of lipid medication. J Nutr 2010;140(1):88-94.
  50. Byrne MJ, Zatta A, Galli C, Power JM, Kaye DM. Recirculating delivery improves myocardial cell engraftment. J Interv Cardiol 2010;23(1):14-7.
  51. Cadilhac DA, Dewey HM, Vos T, Carter R, Thrift AG. The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS). Health Qual Life Outcomes 2010;8:49.
  52. Cadilhac DA, Lannin NA, Anderson CS, Levi CR, Faux S, Price C, Middleton S, Lim J, Thrift AG, Donnan GA. Protocol and pilot data for establishing the Australian Stroke Clinical Registry. Int J Stroke 2010;5(3):217-26.
  53. Cameron AJ, Sicree RA, Zimmet PZ, Alberti KG, Tonkin AM, Balkau B, Tuomilehto J, Chitson P, Shaw JE. Cut-points for waist circumference in Europids and South Asians. Obesity 2010;18(10):2039-46.
  54. Cameron J, Dart AM. Determinants of raised pulse pressure in women. J Am Coll Cardiol 2010;55(12):1279. Letter.
  55. Cameron J, Worrall-Carter L, Page K, Riegel B, Lo SK, Stewart S. Does cognitive impairment predict poor self-care in patients with heart failure? Eur J Heart Fail 2010;12(5):508-15.
  56. Cameron J, Worrall-Carter L, Page K, Stewart S. Self-care behaviours and heart failure: does experience with symptoms really make a difference? Eur J Cardiovasc Nurs 2010;9(2):92-100.
  57. Cao Z, Cooper ME, Allen TJ, Toh B-H, Chai Z. Role for cell division autoantigen 1 in mediating TGF-beta downstream signaling and extracellular matrix protein production in diabetic atherosclerosis. J Clin Metab Diabetes 2010;1(2):29-33. Review.
  58. Cardoso LE, Little PJ, Ballinger ML, Chan CK, Braun KR, Potter-Perigo S, Bornfeldt KE, Kinsella MG, Wight TN. Platelet-derived growth factor differentially regulates the expression and post-translational modification of versican by arterial smooth muscle cells through distinct protein kinase C and extracellular signal-regulated kinase pathways. J Biol Chem 2010;285(10):6987-95.
  59. Carrington MJ, Jennings GL, Stewart S. Pattern of blood pressure in Australian adults: results from a National Blood Pressure Screening Day of 13,825 adults. Int J Cardiol 2010;145(3):461-7.
  60. Carrington MJ, Stewart S; NIL-CHF Study Investigators. Bridging the gap in heart failure prevention: rationale and design of the Nurse-led Intervention for Less Chronic Heart Failure (NIL-CHF) Study. Eur J Heart Fail 2010;12(1):82-8.
  61. Chau JY, der Ploeg HP, van Uffelen JG, Wong J, Riphagen I, Healy GN, Gilson ND, Dunstan DW, Bauman AE, Owen N, Brown WJ. Are workplace interventions to reduce sitting effective? A systematic review. Prev Med 2010;51(5):352-6. Review.
  62. Chen D, La Greca L, Head GA, Walther T, Mayorov DN. The day-night difference of blood pressure is increased in AT1A-receptor knockout mice on a high-sodium diet. Am J Hypertens 2010;23(5):481-7.
  63. Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 2010;192(4):197-202.
  64. Chew P, Yuen DY, Stefanovic N, Pete J, Coughlan MT, Jandeleit-Dahm KA, Thomas MC, Rosenfeldt F, Cooper ME, de Haan JB. Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse. Diabetes 2010;59(12):3198-207.
  65. Christensen DL, Witte DR, Kaduka L, Jørgensen ME, Borch-Johnsen K, Mohan V, Shaw JE, Tabák AG, Vistisen D. Moving to an A1C-based diagnosis of diabetes has a different impact on prevalence in different ethnic groups. Diabetes Care 2010;33(3):580-2.
  66. Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, Kaye DM. Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 2010;176(4):1735-42.
  67. Clark BK, Sugiyama T, Healy GN, Salmon J, Dunstan DW, Shaw JE, Zimmet PZ, Owen N. Socio-demographic correlates of prolonged television viewing time in Australian men and women: the AusDiab study. J Phys Act Health 2010;7(5):595-601.
  68. Clifton P. Nutrition in people with poorly controlled Type 2 diabetes. BMJ 2010;341:c3393. Editorial.
  69. Clifton P. Diabetes: treatment of Type 2 diabetes mellitus with bariatric surgery. Nat Rev Endocrinol 2010;6(4):191-3. Review.
  70. Clifton PM. Nutrition and metabolism. Curr Opin Lipidol 2010;21(2):155-6. Review.
  71. Cohen N. Diabetes: intensive glucose-lowering therapy-weighing up the evidence. Nat Rev Endocrinol 2010;6(1):9-10. Review.
  72. Colagiuri S, Lee CM, Colagiuri R, Magliano D, Shaw JE, Zimmet PZ, Caterson ID. The cost of overweight and obesity in Australia. Med J Aust 2010;192(5):260-4.
  73. Cooper ME, El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ Res 2010;107(12):1403-13.
  74. Crowe SM, Westhorpe CL, Mukhamedova N, Jaworowski A, Sviridov D, Bukrinsky M. The macrophage: the intersection between HIV infection and atherosclerosis. J Leukoc Biol 2010;87(4):589-98. Review.
  75. Cummings N, Dyer TD, Kotea N, Kowlessur S, Chitson P, Zimmet P, Blangero J, Jowett JB. Genome-wide scan identifies a quantitative trait locus at 4p15.3 for serum urate. Eur J Hum Genet 2010;18(11):1243-7.
  76. Cummings N, King R, Rickers A, Kaspi A, Lunke S, Haviv I, Jowett JB. Combining target enrichment with barcode multiplexing for high throughput SNP discovery. BMC Genomics 2010;11:641.
  77. Curran JE, Jowett JB, Abraham LJ, Diepeveen LA, Elliott KS, Dyer TD, Kerr-Bayles LJ, Johnson MP, Comuzzie AG, Moses EK, Walder KR, Collier GR, Blangero J, Kissebah AH. Genetic variation in PARL influences mitochondrial content. Hum Genet 2010;127(2):183-90.
  78. Damasceno A, Gomes J, Azevedo A, Carrilho C, Lobo V, Lopes H, Madede T, Pravinrai P, Silva-Matos C, Jalla S, Stewart S, Lunet N. An epidemiological study of stroke hospitalizations in Maputo, Mozambique: a high burden of disease in a resource-poor country. Stroke 2010;41(11):2463-9.
  79. Davern PJ, Jackson KL, Nguyen-Huu TP, La Greca L, Head GA. Cardiovascular reactivity and neuronal activation to stress in Schlager genetically hypertensive mice. Neuroscience 2010;170(2):551-8.
  80. Davern PJ, Jackson KL, Nguyen-Huu TP, La Greca L, Head GA. Cardiovascular responses to aversive and nonaversive stressors in Schlager genetically hypertensive mice. Am J Hypertens 2010;23(8):838-44.
  81. Davern PJ, McKinley MJ. Forebrain regions affected by lateral parabrachial nucleus serotonergic mechanisms that influence sodium appetite. Brain Res 2010;1339:41-8.
  82. Davies S, Esler M, Nutt D. Anxiety - bridging the heart/mind divide. J Psychopharmacol 2010;24(5):633-8. Review.
  83. Davies-Tuck ML, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, Cicuttini F. Smoking is associated with increased cartilage loss and persistence of bone marrow lesions over 2 years in community-based individuals. Rheumatology 2010;48(10):1227-31.
  84. Davies-Tuck ML, Wluka AE, Forbes A, Wang Y, English DR, Giles GG, O'Sullivan R, Cicuttini FM. Development of bone marrow lesions is associated with adverse effects on knee cartilage while resolution is associated with improvement--a potential target for prevention of knee osteoarthritis: a longitudinal study. Arthritis Res Ther 2010;12(1):R10.
  85. Dawson AP, Steele EJ, Hodges PW, Stewart S. Utility of the Oswestry Disability Index for studies of back pain related disability in nurses: evaluation of psychometric and measurement properties. Int J Nurs Stud 2010;47(5):604-7.
  86. Delles C, Schiffer E, von Zur Muhlen C, Peter K, Rossing P, Parving HH, Dymott JA, Neisius U, Zimmerli LU, Snell-Bergeon JK, Maahs DM, Schmieder RE, Mischak H, Dominiczak AF. Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals. J Hypertens 2010;28(11):2316-22.
  87. Dellios NL, Lappas M, Young IR, Palliser HK, Hirst JJ, Oliva K, Ayhan M, Rice GE. Increased expression of alpha-enolase in cervico-vaginal fluid during labour. Eur J Obstet Gynecol Reprod Biol 2010;153(1):16-22.
  88. Demars J, Shmela ME, Rossignol S, Okabe J, Netchine I, Azzi S, Cabrol S, Le Caignec C, David A, Le Bouc Y, El-Osta A, Gicquel C. Analysis of the IGF2/H19 imprinting control region uncovers new genetic defects, including mutations of OCT-binding sequences, in patients with 11p15 fetal growth disorders. Hum Mol Genet 2010;19(5):803-14.
  89. Di Valentino M, Maeder MT, Jaggi S, Schumann J, Sommerfeld K, Piazzalonga S, Hoffmann A. Prognostic value of cycle exercise testing prior to and after outpatient cardiac rehabilitation. Int J Cardiol 2010;140(1):34-41.
  90. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol Regul Integr Comp Physiol 2010;298(2):R245-53. Review.
  91. Dixon JB. The effect of obesity on health outcomes. Mol Cell Endocrinol 2010;316(2):104-8. Editorial.
  92. D'Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D. Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein. Circ Res 2010;107(2):217-27.
  93. Du AT, Onan D, Dinh DT, Lew MJ, Ziogas J, Aguilar MI, Pattenden LK, Thomas WG. Ligand-supported purification of the urotensin-II receptor. Mol Pharmacol 2010;78(4):639-47.
  94. Du XJ, Bathgate RA, Samuel CS, Dart AM, Summers RJ. Cardiovascular effects of relaxin: from basic science to clinical therapy. Nat Rev Cardiol 2010;7(1):48-58. Review.
  95. Duffy SJ, Ruygrok P, Juergens CP, Sievert H, Richards M, Blake J, Whitbourn R, Farouque HO, Pertile T, Kaye DM. Removal of contrast media from the coronary sinus attenuates renal injury after coronary angiography and intervention. J Am Coll Cardiol 2010;56(6):525-6.
  96. Dunstan DW, Barr ELM, Healy GN, Salmon J, Shaw JE, Balkau B, Magliano DJ, Cameron AJ, Zimmet PZ, Owen N. Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation 2010;121(3):384-91.
  97. Dunstan DW, Barr ELM, Shaw JE, Magliano DJ, Zimmet PZ, Salmon J, Cameron AJ, Owen N, Healy GN, Balkau B. Response to letters regarding article, "Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab)". Circulation 2010;122(13):e473. Author reply.
  98. Dupic L, Huet O, Harrois A, Duranteau J. Hypoxia and mitochondrial function. Réanimation 2010;19(5):399-405. Review.
  99. Eades SJ, Read AW, McAullay D, McNamara B, O'Dea K, Stanley FJ. Modern and traditional diets for Noongar infants. J Paediatr Child Health 2010;46(7-8):398-403.
  100. Eades SJ, Taylor B, Bailey S, Williamson AB, Craig JC, Redman S; SEARCH Investigators. The health of urban Aboriginal people: insufficient data to close the gap. Med J Aust 2010;193(9):521-4. Review.
  101. Eakin EG, Reeves MM, Marshall AL, Dunstan DW, Graves N, Healy GN, Bleier J, Barnett AG, O'Moore-Sullivan T, Russell A, Wilkie K. Living Well with Diabetes: a randomized controlled trial of a telephone-delivered intervention for maintenance of weight loss, physical activity and glycaemic control in adults with Type 2 diabetes. BMC Public Health 2010;10:452. Protocol.
  102. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2010;375(9710):181-3.
  103. Edgell TA, Barraclough DL, Rajic A, Dhulia J, Lewis KJ, Armes JE, Barraclough R, Rudland PS, Rice GE, Autelitano DJ. Increased plasma concentrations of anterior gradient 2 protein are positively associated with ovarian cancer. Clin Sci 2010;118(12):717-25.
  104. Egger G, Dixon J. Inflammatory effects of nutritional stimuli: further support for the need for a big picture approach to tackling obesity and chronic disease. Obes Rev 2010;11(2):137-49. Review.
  105. Egger GJ, Dixon JB. Obesity and global warming: are they similar "canaries" in the same "mineshaft"? Med J Aust 2010;193(11-12):635-7. Editorial.
  106. Esler M. The 2009 Carl Ludwig Lecture: Pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010;108(2):227-37. Review.
  107. Esler M. Sympathetic nervous activation in essential hypertension: commonly neglected as a therapeutic target, usually ignored as a drug side effect. Hypertension 2010;55(5):1090-1. Editorial.
  108. Esler M, Lambert E, Schlaich M. Point: Chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 2010;109(6):1996-8; discussion 2016. Review.
  109. Esler MD, Masuo K. Pharmacological treatments for obesity-related hypertension. Curr Hypertens Rev 2010;6(2):92-9. Review.
  110. Evans RG, Eppel GA, Michaels S, Burke SL, Nematbakhsh M, Head GA, Carroll JF, O'Connor PM. Multiple mechanisms act to maintain kidney oxygenation during renal ischemia in anesthetized rabbits. Am J Physiol Renal Physiol 2010;298(5):F1235-F1243.
  111. Evans RG, Head GA, Eppel GA, Burke SL, Rajapakse NW. Angiotensin II and neurohumoral control of the renal medullary circulation. Clin Exp Pharmacol Physiol 2010;37(2):e58-69. Review.
  112. Fang L, Du XJ, Gao XM, Dart AM. Activation of peripheral blood mononuclear cells and extracellular matrix and inflammatory gene profile in acute myocardial infarction. Clin Sci 2010;119(4):175-83.
  113. Febbraio MA, Rose-John S, Pedersen BK. Is interleukin-6 receptor blockade the Holy Grail for inflammatory diseases? Clin Pharmacol Ther 2010;87(4):396-8. Comment.
  114. Fernandez AZ, Siebel AL, El-Osta A. Atherogenic factors and their epigenetic relationships. Int J Vasc Med 2010;2010:437809. Review.
  115. Forbes JM. The physiological deadlock between AMPK and gluconeogenesis: SOGA, a novel protein, may provide the key. Am J Pathol 2010;177(4):1600-2. Editorial.
  116. Fu Y. Rate-limiting factors of cholesterol efflux in reverse cholesterol transport: acceptors and donors. Clin Exp Pharmacol Physiol 2010;37(7):703-9. Review.
  117. Furnish EJ, Brophy CM, Harris VA, Macomson S, Winger J, Head GA, Shaver EG. Treatment with transducible phosphopeptide analogues of the small heat shock-related protein, HSP20, after experimental subarachnoid hemorrhage: prevention and reversal of delayed decreases in cerebral perfusion. J Neurosurg 2010;112(3):631-9.
  118. Gagnon C, Magliano DJ, Ebeling PR, Dunstan DW, Zimmet PZ, Shaw JE, Daly RM. Association between hyperglycaemia and fracture risk in non-diabetic middle-aged and older Australians: a national, population-based prospective study (AusDiab). Osteoporos Int 2010;21(12):2067-74.
  119. Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ, Haviv I. MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer. Bioinformatics 2010;26(2):161-7.
  120. Gall SL, Donnan G, Dewey H, Thrift A. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010;75(7):670-1. Author reply.
  121. Gall SL, Donnan G, Dewey HM, Macdonell R, Sturm J, Gilligan A, Srikanth V, Thrift AG. Sex differences in presentation, severity, and management of stroke in a population-based study. Neurology 2010;74(12):975-81.
  122. Gao XM, Ming Z, Su Y, Fang L, Kiriazis H, Xu Q, Dart AM, Du XJ. Infarct size and post-infarct inflammation determine the risk of cardiac rupture in mice. Int J Cardiol 2010;143(1):20-8.
  123. Genovese G, Tonna SJ, Knob AU, Appel GB, Katz A, Bernhardy AJ, Needham AW, Lazarus R, Pollak MR. A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9. Kidney Int 2010;78(7):698-704.
  124. Georgiadis JR, Farrell MJ, Boessen R, Denton DA, Gavrilescu M, Kortekaas R, Renken RJ, Hoogduin JM, Egan GF. Dynamic subcortical blood flow during male sexual activity with ecological validity: a perfusion fMRI study. Neuroimage 2010;50(1):208-16.
  125. Getachew R, Ballinger ML, Burch ML, Little PJ, Osman N. Characterisation of Ki11502 as a potent inhibitor of PDGF beta receptor-mediated proteoglycan synthesis in vascular smooth muscle cells. Eur J Pharmacol 2010;626(2-3):186-92.
  126. Getachew R, Ballinger ML, Burch ML, Reid JJ, Khachigian LM, Wight TN, Little PJ, Osman N. PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology 2010;151(9):4356-67.
  127. Gibson JH, Slobedman B, Kaipananickal H, Williamson SL, Minchenko D, El-Osta A, Stern JL, Christodoulou J. Downstream targets of methyl CpG binding protein 2 and their abnormal expression in the frontal cortex of the human Rett syndrome brain. BMC Neurosci 2010;11:53.
  128. Gilligan C, Sanson-Fisher R, Eades S, Wenitong M, Panaretto K, D'Este C. Assessing the accuracy of self-reported smoking status and impact of passive smoke exposure among pregnant Aboriginal and Torres Strait Islander women using cotinine biochemical validation. Drug Alcohol Rev 2010;29(1):35-40.
  129. Giunti S, Calkin AC, Forbes JM, Allen TJ, Thomas MC, Cooper ME, Jandeleit-Dahm KA. The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse. Am J Physiol Renal Physiol 2010;299(3):F528-35.
  130. Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics 2010;9(11):2424-37.
  131. Grantham NM, Magliano DJ, Tai G, Cohen N, Shaw JE. Anti-platelets in diabetes management. Intern Med J 2010;40(6):458-62.
  132. Grills N, Piers LS, Barr I, Vaughan LM, Lester R, Magliano DJ, Shaw JE, Carnie JA. A lower than expected adult Victorian community attack rate for pandemic (H1N1) 2009. Aust N Z J Public Health 2010;34(3):228-31. Erratum: Aust N Z J Public Health 2010;34(4):426.
  133. Guild SJ, Barrett CJ, McBryde FD, Van Vliet BN, Head GA, Burke SL, Malpas SC. Quantifying sympathetic nerve activity: problems, pitfalls and the need for standardization. Exp Physiol 2010;95(1):41-50. Review.
  134. Gurvitch R, Lefkovits J, Warren RJ, Duffy SJ, Clark DJ, Eccleston D, Yan BP, Reid C, Brennan A, Andrianopoulos N, Ajani AE. Clinical outcomes of drug-eluting stent use in patients with ST-elevation myocardial infarction. Int J Cardiol 2010;143(3):283-8.
  135. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2010;87(4):694-703.
  136. Habersberger J, Eisenhardt S, Peter K. C-reactive protein measurement and cardiovascular disease. Lancet 2010;375(9720):1078. Letter.
  137. Hagemeyer CE, Ahrens I, Bassler N, Dschachutaschwili N, Chen YC, Eisenhardt SU, Bode C, Peter K. Genetic transfer of fusion proteins effectively inhibits VCAM-1-mediated cell adhesion and transmigration via inhibition of cytoskeletal anchorage. J Cell Mol Med 2010;14(1-2):290-302.
  138. Hagemeyer CE, Bürck C, Schwab R, Knoth R, Meyer RP. 7-Benzyloxyresorufin-O-dealkylase activity as a marker for measuring cytochrome P450 CYP3A induction in mouse liver. Anal Biochem 2010;398(1):104-11.
  139. Hagemeyer CE, Peter K. Targeting the platelet integrin GPIIb/IIIa. Curr Pharm Des 2010;16(37):4119-33. Review.
  140. Harikrishnan KN, Bayles R, Ciccotosto GD, Maxwell S, Cappai R, Pelka GJ, Tam PP, Christodoulou J, El-Osta A. Alleviating transcriptional inhibition of the norepinephrine Slc6a2 transporter gene in depolarized neurons. J Neurosci 2010;30(4):1494-501.
  141. Hayden MJ, Dixon JB, Dixon ME, O'Brien PE. Confirmatory factor analysis of the Beck Depression Inventory in obese individuals seeking surgery. Obes Surg 2010;20(4):432-9.
  142. Hayden MJ, Dixon ME, Dixon JB, Playfair J, O'Brien PE. Perceived discrimination and stigmatisation against severely obese women: age and weight loss make a difference. Obes Facts 2010;3(1):7-14.
  143. Head GA. Exciting challenges ahead for integrative and regulatory physiology. Front Integr Physiol 2010:doi: 10.3389/fphys.2010.00127. Review.
  144. Head GA, Burke SL. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. activation of the intrarenal renin-angiotensin system. J Appl Physiol 2010;109(6):2010. Comment.
  145. Head GA, Chatzivlastou K, Lukoshkova EV, Jennings GL, Reid CM. A novel measure of the power of the morning blood pressure surge from ambulatory blood pressure recordings. Am J Hypertens 2010;23(10):1074-81.
  146. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M; Ambulatory Blood Pressure Working Group of the High Blood Pressure Research Council of Australia. Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. Br Med J 2010;340:c1104.
  147. Head GA, Mihailidou AS, Duggan KA, Beilin LJ, Berry N, Brown MA, Bune AJ, Cowley D, Chalmers JP, Howe PR, Hodgson J, Ludbrook J, Mangoni AA, McGrath BP, Nelson MR, Sharman JE, Stowasser M. Reply to: "Clinical thresholds for ambulatory blood pressure measurement reinvented?" Br Med J 2010;Rapid response:14 May. Author reply.
  148. Healy GN, Owen N. Sedentary conduct and biomarkers of cardiometabolic risk in adolescents: a scientific and emerging public health problem. Rev Esp Cardiol 2010;63(3):261-4. Editorial.
  149. Hietala K, Harjutsalo V, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Age at onset and the risk of proliferative retinopathy in Type 1 diabetes. Diabetes Care 2010;33(6):1315-9.
  150. Heng YJ, Di Quinzio MK, Permezel M, Ayhan M, Rice GE, Georgiou HM. Temporal proteomic analysis of human cervicovaginal fluid with impending term labor. J Proteome Res 2010;9(3):1344-50.
  151. Hennebry SC, Eikelis N, Socratous F, Desir G, Lambert G, Schlaich M. Renalase, a novel soluble FAD-dependent protein, is synthesized in the brain and peripheral nerves. Mol Psychiatry 2010;15(3):234-6.
  152. Henstridge DC, Febbraio MA. Adiponectin sparks an interest in calcium. Cell Metab 2010;11(6):447-9. Comment.
  153. Henstridge DC, Forbes JM, Penfold SA, Formosa MF, Dougherty S, Gasser A, de Courten MP, Cooper ME, Kingwell BA, de Courten B. The relationship between heat shock protein 72 expression in skeletal muscle and insulin sensitivity is dependent on adiposity. Metabolism 2010;59(11):1556-61.
  154. Hodge AM, Maple-Brown L, Cunningham J, Boyle J, Dunbar T, Weeramanthri T, Shaw J, O'Dea K. Abdominal obesity and other risk factors largely explain the high CRP in Indigenous Australians relative to the general population, but not gender differences: a cross-sectional study. BMC Public Health 2010;10:700.
  155. Holdsworth-Carson S, Lim R, Mitton A, Whitehead C, Rice G, Permezel M, Lappas M. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 2010;31(3):222-9.
  156. Hume C, Dunstan D, Salmon J, Healy G, Andrianopoulos N, Owen N. Are barriers to physical activity similar for adults with and without abnormal glucose metabolism? Diabetes Educ 2010;36(3):495-502.
  157. Huynh K, McMullen JR, Julius TL, Tan JW, Love JE, Cemerlang N, Kiriazis H, Du XJ, Ritchie RH. Cardiac-specific IGF-1 receptor transgenic expression protects against cardiac fibrosis and diastolic dysfunction in a mouse model of diabetic cardiomyopathy. Diabetes 2010;59(6):1512-20.
  158. Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, Stewart S, Cleland JG. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010;(8):CD007228. Review.
  159. Inglis SC, McMurray JJ, Böhm M, Schaufelberger M, van Veldhuisen DJ, Lindberg M, Dunselman P, Hjalmarson A, Kjekshus J, Waagstein F, Wedel H, Wikstrand J; CORONA Study Group. Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA). Eur J Heart Fail 2010;12(7):698-705.
  160. Ireland DM, Clifton PM, Keogh JB. Achieving the salt intake target of 6 g/day in the current food supply in free-living adults using two dietary education strategies. J Am Diet Assoc 2010;110(5):763-7.
  161. Jennings G. Obesity and left ventricular hypertrophy: does my heart look big on this? J Hypertens 2010;28(11):2190-3. Editorial.
  162. Jennings G, Parati G. Blood pressure up in a puff of smoke. J Hypertens 2010;28(9):1806-8. Editorial.
  163. Jennings GL. Hypertension and adherence to physical activity programs--a sticky matter! Br J Sports Med 2010;44(14):994-7. Editorial.
  164. Jeremy R, Tonkin A, White H, Riddell T, Brieger D, Walsh W, Zeitz C, Brown A, Kritharides L. Improving cardiovascular care for indigenous populations. Heart Lung Circ 2010;19(5-6):344-50. Review.
  165. Jeremy RW, Brown A. Measuring the gap-it may well be worse than we thought. Heart Lung Circ 2010;19(12):695-6. Editorial.
  166. Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, Ness RB, Moysich KB, Chang-Claude J, Wang-Gohrke S, Cramer DW, Terry KL, Hankinson SE, Tworoger SS, Garcia-Closas M, Yang H, Lissowska J, Chanock SJ, Pharoah PD, Song H, Whitemore AS, Pearce CL, Stram DO, Wu AH, Pike MC, Gayther SA, Ramus SJ, Menon U, Gentry-Maharaj A, Anton-Culver H, Ziogas A, Hogdall E, Kjaer SK, Hogdall C, Berchuck A, Schildkraut JM, Iversen ES, Moorman PG, Phelan CM, Sellers TA, Cunningham JM, Vierkant RA, Rider DN, Goode EL, Haviv I, Chenevix-Trench G; Ovarian Cancer Association Consortium; Australian Ovarian Cancer Study Group; Australian Cancer Study (Ovarian Cancer). Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". PLoS Genet 2010;6(7):e1001016.
  167. Jowett JB. Interplay of genetic and environmental factors: innate immunity genetic polymorphisms in MBL2 affect endothelial dysfunction and risk of atherosclerosis. Atherosclerosis 2010;208(1):32-3. Comment.
  168. Jowett JBM, Blangero J. Response to Comment on: Jowett et al. (2010) Genetic Variation at the FTO Locus Influences RBL2 Gene Expression. Diabetes;59:726-732. Diabetes 2010;59(7):e10. Author reply.
  169. Jowett JB, Curran JE, Johnson MP, Carless MA, Göring HH, Dyer TD, Cole SA, Comuzzie AG, Maccluer JW, Moses EK, Blangero J. Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes 2010;59(3):726-32.
  170. Kamili A, Wat E, Chung RW, Tandy S, Weir JM, Meikle PJ, Cohn JS. Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutr Metab 2010;7:90.
  171. Kanellakis P, Pomilio G, Agrotis A, Gao X, Du XJ, Curtis D, Bobik A. Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common -chain heteroreceptor. Br J Pharmacol 2010;160(8):2085-96.
  172. Karagiannis TC, Lin AJ, Ververis K, Chang L, Tang MM, Okabe J, El-Osta A. Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes. Aging 2010;2(10):659-68.
  173. Karagounis LG, Yaspelkis BB 3rd, Reeder DW, Lancaster GI, Hawley JA, Coffey VG. Contraction-induced changes in TNF and Akt-mediated signalling are associated with increased myofibrillar protein in rat skeletal muscle. Eur J Appl Physiol 2010;109(5):839-48.
  174. Kavanagh A, Bentley RJ, Turrell G, Shaw J, Dunstan D, Subramanian SV. Socioeconomic position, gender, health behaviours and biomarkers of cardiovascular disease and diabetes. Soc Sci Med 2010;71(6):1150-60.
  175. Kaye DM, Byrne MJ, Power JM. Reply to Bridges. Gene Ther 2010;17(4):565-6. Author reply.
  176. Kaye DM, Iles L, Taylor AJ. Myocardial fibrosis in hypertrophic cardiomyopathy. N Engl J Med 2010;363(20):1971. Letter.
  177. Keogh JB, Woonton BW, Taylor CM, Janakievski F, Desilva K, Clifton PM. Effect of glycomacropeptide fractions on cholecystokinin and food intake. Br J Nutr 2010;104(2):286-90.
  178. Kimura E, Li S, Gregorevic P, Fall BM, Chamberlain JS. Dystrophin delivery to muscles of mdx mice using lentiviral vectors leads to myogenic progenitor targeting and stable gene expression. Mol Ther 2010;18(1):206-13.
  179. King AC, Goldberg JH, Salmon J, Owen N, Dunstan D, Weber D, Doyle C, Robinson TN. Identifying subgroups of U.S. adults at risk for prolonged television viewing to inform program development. Am J Prev Med 2010;38(1):17-26.
  180. Kistler PM, Teh AW. Pulmonary vein tachycardia: is the sinus rhythm P-wave useful. Rev Esp Cardiol 2010;63(2):134-6. Editorial.
  181. Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, Schmidt HH. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 2010;8(9):pii:e1000479.
  182. Koïtka A, Cao Z, Koh P, Watson AM, Sourris KC, Loufrani L, Soro-Paavonen A, Walther T, Woollard KJ, Jandeleit-Dahm KA, Cooper ME, Allen TJ. Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. Diabetologia 2010;53(3):584-92.
  183. Korner PI. The phenotypic patterns of essential hypertension are the key to identifying "high blood pressure" genes. Physiol Res 2010;59(6):841-57. Review.
  184. Kritharides L, Brown A, Brieger D, Ridell T, Zeitz C, Jeremy R, Tonkin A, Walsh W, White H. Overview and determinants of cardiovascular disease in indigenous populations. Heart Lung Circ 2010;19(5-6):337-43. Review.
  185. Kritharides L, Brown A, Brieger D, Ridell T, Zeitz C, Jeremy R, Tonkin A, Walsh W, White H; CSANZ IHC Writing Group. Recommendations arising from the inaugural CSANZ Conference on Indigenous Cardiovascular Health. Heart Lung Circ 2010;19(5-6):269-72. Comment.
  186. Kyaw T, Tay C, Khan A, Dumouchel V, Cao A, To K, Kehry M, Dunn R, Agrotis A, Tipping P, Bobik A, Toh BH. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J Immunol 2010;185(7):4410-9.
  187. Lambers Heerspink HJ, Gansevoort RT, Brenner BM, Cooper ME, Parving HH, Shahinfar S, de Zeeuw D. Comparison of different measures of urinary protein excretion for prediction of renal events. J Am Soc Nephrol 2010;21(8):1355-60.
  188. Lambers Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, Cooper M, Grobbee DE, Mancia G, Mogensen CE, Neal B, Chalmers J; for the ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide in patients with Type 2 diabetes and chronic kidney disease. Eur Heart J 2010;31(23):2888-96.
  189. Lambert E, Dawood T, Straznicky N, Sari C, Schlaich M, Esler M, Lambert G. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure. J Hypertens 2010;28(3):543-50.
  190. Lambert E, Sari CI, Dawood T, Nguyen J, McGrane M, Eikelis N, Chopra R, Wong C, Chatzivlastou K, Head G, Straznicky N, Esler M, Schlaich M, Lambert G. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension 2010;56(3):351-8.
  191. Lambert G, Grassi G. Indices of sympathetic activity and the paradox of chromogranin A. J Hypertens 2010;28(4):676-8. Editorial.
  192. Lambert G, Schlaich M, Lambert E, Dawood T, Esler M. Stress reactivity and its association with increased cardiovascular risk: a role for the sympathetic nervous system? Hypertension 2010;55(6):e20. Letter.
  193. Lambert GW, Masuo K. Imidazoline receptor agonists in obesity-related hypertension: therapeutic targeting of the sympathetic nervous system. Immun Endoc Metab Agents Med Chem 2010;10(2):59-65. Review.
  194. Lambert GW, Straznicky NE, Lambert EA, Dixon JB, Schlaich MP. Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. Pharmacol Ther 2010;126(2):159-72. Review.
  195. Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, Freeman M, Charter K, Duffy SJ, Ajani AE, Proietto J, Farouque O; MIG (Melbourne Interventional Group) Registry. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. JACC Cardiovasc Interv 2010;3(6):660-8.
  196. Le Bouc Y, Rossignol S, Azzi S, Brioude F, Cabrol S, Gicquel C, Netchine I. Epigenetics, genomic imprinting and developmental disorders. Bull Acad Natl Med 2010;194(2):287-97. Review.
  197. Le Bouc Y, Rossignol S, Azzi S, Steunou V, Netchine I, Gicquel C. Epigenetics, genomic imprinting and assisted reproductive technology. Ann Endocrinol 2010;71(3):237-8. Review.
  198. Lee G, Wu H, Kalman JM, Esmore D, Williams T, Snell G, Kistler PM. Atrial fibrillation following lung transplantation: double but not single lung transplant is associated with long-term freedom from paroxysmal atrial fibrillation. Eur Heart J 2010;31(22):2774-82.
  199. Lilja M, Rolandsson O, Shaw JE, Pauvaday V, Cameron AJ, Tuomilehto J, Alberti KG, Zimmet PZ, Söderberg S. Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk. Int J Obes 2010;34(5):878-85.
  200. Lim AK, Ma FY, Nikolic-Paterson DJ, Kitching AR, Thomas MC, Tesch GH. Lymphocytes promote albuminuria, but not renal dysfunction or histological damage in a mouse model of diabetic renal injury. Diabetologia 2010;53(8):1772-82.
  201. Lim SS, Noakes M, Keogh JB, Clifton PM. Long-term effects of a low carbohydrate, low fat or high unsaturated fat diet compared to a no-intervention control. Nutr Metab Cardiovasc Dis 2010;20(8):599-607.
  202. Lin RC, Weeks KL, Gao XM, Williams RB, Bernardo BC, Kiriazis H, Matthews VB, Woodcock EA, Bouwman RD, Mollica JP, Speirs HJ, Dawes IW, Daly RJ, Shioi T, Izumo S, Febbraio MA, Du XJ, McMullen JR. PI3K(p110alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA. Arterioscler Thromb Vasc Biol 2010;30(4):724-32.
  203. Lin T, Santos M, Aboltins C, Chiu H, Van Gaal W, Wong C. A case of intra-cardiac right-sided mural infective endocarditis associated with ventricular septal defect despite prophylactic antibiotics: a case report. Heart Lung Circ 2010;19(9):566-71.
  204. Little PJ, Bhattacharya R, Moreyra AE, Korichneva IL. Zinc and cardiovascular disease. Nutrition 2010;26(11-12):1050-7. Review.
  205. Little PJ, Burch ML, Getachew R, Al-aryahi S, Osman N. Endothelin-1 stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by endothelin receptor transactivation of the transforming growth factor-beta type I receptor. J Cardiovasc Pharmacol 2010;56(4):360-8.
  206. Liu H, Patel A, Brown A, Eades S, Hayman N, Jan S, Ring I, Stewart G, Tonkin A, Weeramanthri T, Wade V, Rodgers A, Usherwood T, Neal B, Peiris D, Burke H, Reid C, Cass A; Kanyini Vascular Collaboration, Kanyini GAP Study Team. Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk. BMC Public Health 2010;10:458. Protocol.
  207. Louis SN, Chow L, Rezmann L, Krezel MA, Catt KJ, Tikellis C, Frauman AG, Louis WJ. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. Prostate 2010;70(14):1563-74.
  208. Lu ZX, Walker KZ, O'Dea K, Sikaris KA, Shaw JE. A1C for screening and diagnosis of Type 2 diabetes in routine clinical practice. Diabetes Care 2010;33(4):817-9.
  209. Lumsden NG, Khambata RS, Hobbs AJ. C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des 2010;16(37):4080-8. Review.
  210. Lynch BM, Dunstan DW, Healy GN, Winkler E, Eakin E, Owen N. Objectively measured physical activity and sedentary time of breast cancer survivors, and associations with adiposity: findings from NHANES (2003-2006). Cancer Causes Control 2010;21(2):283-8.
  211. Lynch BM, Healy GN, Dunstan DW, Owen N. Sedentary versus inactive: distinctions for disease prevention. Nat Rev Cardiol 2010;7(11):doi:10.1083/nrcardio.2010.68-c1. Letter.
  212. Lynch BM, White SL, Owen N, Healy GN, Chadban SJ, Atkins RC, Dunstan DW. Television viewing time and risk of chronic kidney disease in adults: the AusDiab Study. Ann Behav Med 2010;40(3):265-74.
  213. Macintyre G, Bailey J, Gustafsson D, Haviv I, Kowalczyk A. Using gene ontology annotations in exploratory microarray clustering to understand cancer etiology. Pattern Recogn Lett 2010;31(14):2138-46.
  214. Macintyre G, Bailey J, Haviv I, Kowalczyk A. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 2010;26(18):i524-30.
  215. MacLaren DJ, Conigrave KM, Robertson JA, Ivers RG, Eades S, Clough AR. Using breath carbon monoxide to validate self-reported tobacco smoking in remote Australian Indigenous communities. Popul Health Metr 2010;8(1):2.
  216. Maeder MT, Ammann P, Schoch OD, Rickli H, Korte W, Hürny C, Myers J, Münzer T. Determinants of postexercise heart rate recovery in patients with the obstructive sleep apnea syndrome. Chest 2010;137(2):310-7.
  217. Maeder MT, Brutsche MH, Arenja N, Socrates T, Reiter M, Meissner J, Staub D, Morgenthaler NG, Bergmann A, Mueller C. Biomarkers and peak oxygen uptake in patients with chronic lung disease. Respiration 2010;80(6):543-52.
  218. Maeder MT, Brutsche MH, Christ A, Staub D, Noveanu M, Breidthardt T, Schaub N, Potocki M, Reichlin T, Morgenthaler NG, Bergmann A, Mueller C. Midregional pro-A-type natriuretic peptide for the evaluation of exercise intolerance. Int J Cardiol 2010;145(2):326-8.
  219. Maeder MT, Duerring C, Engel RP, Boesch C, Pfisterer ME, Myers J, Müller-Brand J, Zellweger MJ. Predictors of impaired heart rate recovery: a myocardial perfusion SPECT study. Eur J Cardiovasc Prev Rehabil 2010;17(3):303-8.
  220. Maeder MT, Kaye DM. Response to Does the wall stress alone stimulate the natriuretic peptide system? Hypertension 2010;56(6):e176. Author reply.
  221. Maeder MT, Mariani JA, Kaye DM. Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress. Hypertension 2010;56(4):682-9.
  222. Maeder MT, Thompson BR, Brunner-La Rocca HP, Kaye DM. Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction. J Am Coll Cardiol 2010;56(11):855-63.
  223. Magliano DJ, Söderberg S, Zimmet PZ, Cartensen B, Balkau B, Pauvaday V, Kowlessur S, Tuomilehto J, Alberti KG, Shaw JE. Mortality, all-cause and cardiovascular disease, over 15 years in multiethnic Mauritius: impact of diabetes and intermediate forms of glucose tolerance. Diabetes Care 2010;33(9):1983-9.
  224. Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia 2010 ;24(4):679-86. Review.
  225. Mah LJ, El-Osta A, Karagiannis TC. gammaH2AX as a molecular marker of aging and disease. Epigenetics 2010;5(2):129-36. Review.
  226. Mah LJ, Vasireddy RS, Tang MM, Georgiadis GT, El-Osta A, Karagiannis TC. Quantification of gammaH2AX foci in response to ionising radiation. J Vis Exp 2010;(38):pii:1957.
  227. Mahfoud F, Kindermann M, Ukena C, Sobotka PA, Kindermann I, Schlaich M, Böhm M. Interventional renal denervation for resistant hypertension. J Hypertonie 2010;14(3):18-20. Review.
  228. Maple-Brown LJ, Lawton PD, Hughes JT, Sharma SK, Jones GR, Ellis AG, Hoy W, Cass A, Macisaac RJ, Sinha AK, Thomas MA, Piers LS, Ward LC, Drabsch K, Panagiotopoulos S, McDermott R, Warr K, Cherian S, Brown A, Jerums G, O'Dea K. Study Protocol--accurate assessment of kidney function in Indigenous Australians: aims and methods of the eGFR study. BMC Public Health 2010;10:80. Protocol.
  229. Mariani JA, Dawson MA, Avery S, Taylor AJ. Primary cardiac lymphoma. J Am Coll Cardiol 2010;55(13):e23.
  230. Mariani JA, Kaye DM. Delivery of gene and cellular therapies for heart disease. J Cardiovasc Transl Res 2010;3(4):417-26. Review.
  231. Masuo K. Human recombinant leptin administration as a potential obesity therapy. Immun Endoc Metab Agents Med Chem 2010;10(2):50-4. Review.
  232. Masuo K. Obesity, hypertension, and the metabolic syndrome. Curr Hypertens Rev 2010;6(2):72. Editorial.
  233. Masuo K. Pharmacological treatments for obesity and obesity-hypertension. Immun Endoc Metab Agents Med Chem 2010;10(2):43. Editorial.
  234. Masuo K. Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome. Int J Hypertens 2010;2010:832821. Review.
  235. Masuo K, Esler MD. Role of sympathetic nerve activity in obesity, hypertension and metabolic syndrome. Curr Hypertens Rev 2010;6(2):83-91. Review.
  236. Masuo K, Esler MD, Lambert GW. Pharmacological treatments for obesity. Immun Endoc Metab Agents Med Chem 2010;10(2):44-9. Review.
  237. Masuo K, Lambert GW. Calcium channel blockers in obesity-related hypertension. Immun Endoc Metab Agents Med Chem 2010;10(2):66-75. Review.
  238. Masuo K, Lambert GW, Esler MD. Epinephrine and its role in the development of obesity, hypertension and obesity-related hypertension. Int J Med Biol Front 2010;15(5-6):371-86.
  239. Masuo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous activity in renal injury and end-stage renal disease. Hypertens Res 2010;33(6):521-8. Review.
  240. Masuo K, Lambert GW, Dixon JB. Weight loss in obesity and metabolic syndrome. Curr Hypertens Rev 2010;6(2):130-8. Review.
  241. Masuo K, Rakugi H, Ogihara T. Relationships of beta2- and beta3-adrenoceptor polymorphisms with obesity, hypertension and metabolic syndrome. Curr Hypertens Rev 2010;6(2):118-29. Review.
  242. Masuo K, Rakugi H, Ogihara T, Esler MD, Lambert GW. Cardiovascular and renal complications of Type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance. Curr Diabetes Rev 2010;6(2):58-67. Review.
  243. Mathiyalagan P, Chang L, Du XJ, El-Osta A. Cardiac ventricular chambers are epigenetically distinguishable. Cell Cycle 2010;9(3):612-7.
  244. Matthews VB, Allen TL, Risis S, Chan MH, Henstridge DC, Watson N, Zaffino LA, Babb JR, Boon J, Meikle PJ, Jowett JB, Watt MJ, Jansson JO, Bruce CR, Febbraio MA. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010;53(11):2431-41.
  245. McLellan A, Taylor AJ. Managing diabetics with coronary artery disease. Diabetes Manag J 2010;30:10. Review.
  246. McLennan SN, Mathias JL, Brennan LC, Russell ME, Stewart S. Cognitive impairment predicts functional capacity in dementia-free patients with cardiovascular disease. J Cardiovasc Nurs 2010;25(5):390-7.
  247. Mellor K, Ritchie RH, Meredith G, Woodman OL, Morris MJ, Delbridge LM. High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy. Nutrition 2010;26(7-8):842-8.
  248. Mellor KM, Ritchie RH, Davidoff AJ, Delbridge LM. Elevated dietary sugar and the heart: experimental models and myocardial remodeling. Can J Physiol Pharmacol 2010;88(5):525-40. Review.
  249. Mellor KM, Ritchie RH, Delbridge LM. Reactive oxygen species and insulin resistant cardiomyopathy. Clin Exp Pharmacol Physiol 2010;37(2):222-8.
  250. Miller AG, Tan G, Binger KJ, Pickering RJ, Thomas MC, Nagaraj RH, Cooper ME, Wilkinson-Berka JL. Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function. Diabetes 2010;59(12):3208-15.
  251. Mischak H, Allmaier G, Apweiler R, Attwood T, Baumann M, Benigni A, Bennett SE, Bischoff R, Bongcam-Rudloff E, Capasso G, Coon JJ, D'Haese P, Dominiczak AF, Dakna M, Dihazi H, Ehrich JH, Fernandez-Llama P, Fliser D, Frokiaer J, Garin J, Girolami M, Hancock WS, Haubitz M, Hochstrasser D, Holman RR, Ioannidis JP, Jankowski J, Julian BA, Klein JB, Kolch W, Luider T, Massy Z, Mattes WB, Molina F, Monsarrat B, Novak J, Peter K, Rossing P, Sánchez-Carbayo M, Schanstra JP, Semmes OJ, Spasovski G, Theodorescu D, Thongboonkerd V, Vanholder R, Veenstra TD, Weissinger E, Yamamoto T, Vlahou A. Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med 2010;2(46):46ps42.
  252. Misso ML, Egberts KJ, Page M, O'Connor D, Shaw J. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for Type 1 diabetes mellitus. Cochrane Database Syst Rev 2010;(1):CD005103. Review.
  253. Mitchell TW, Turner N, Else PL, Hulbert AJ, Hawley JA, Lee JS, Bruce CR, Blanksby SJ. The effect of exercise on the skeletal muscle phospholipidome of rats fed a high-fat diet. Int J Mol Sci 2010;11(10):3954-64.
  254. Moran LJ, Noakes M, Clifton PM, Norman RJ. The effect of modifying dietary protein and carbohydrate in weight loss on arterial compliance and postprandial lipidemia in overweight women with polycystic ovary syndrome. Fertil Steril 2010;94(6):2451-4.
  255. Morrow MP, Grant A, Mujawar Z, Dubrovsky L, Pushkarsky T, Kiselyeva Y, Jennelle L, Mukhamedova N, Remaley AT, Kashanchi F, Sviridov D, Bukrinsky M. Stimulation of the liver X receptor pathway inhibits HIV-1 replication via induction of ATP-binding cassette transporter A1. Mol Pharmacol 2010;78(2):215-25.
  256. Mujawar Z, Tamehiro N, Grant A, Sviridov D, Bukrinsky M, Fitzgerald ML. Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation. Biochemistry 2010;49(38):8338-49.
  257. Murphy AJ, Remaley AT, Sviridov D. HDL therapy: two kinds of right? Curr Pharm Des 2010;16(37):4134-47. Review.
  258. Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 2010;37(7):710-8. Review.
  259. Nestel P. Linoleic acid reassessed. Curr Opin Lipidol 2010;21(3):253-5. Comment.
  260. Nicolaides AN, Kakkos SK, Kyriacou E, Griffin M, Sabetai M, Thomas DJ, Tegos T, Geroulakos G, Labropoulos N, Doré CJ, Morris TP, Naylor R, Abbott AL; Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group. Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification. J Vasc Surg 2010;52(6):1486-96.
  261. Ning F, Qiao Q, Tuomilehto J, Hammar N, Ho SY, Söderberg S, Zimmet PZ, Shaw JE, Nakagami T, Mohan V, Ramachandran A, Lam TH, Andersson SW, Janus ED, Boyko EJ, Fujimoto WY, Pang ZC; DECODA Study Group. Does abnormal insulin action or insulin secretion explain the increase in prevalence of impaired glucose metabolism with age in populations of different ethnicities? Diabetes Metab Res Rev 2010;26(4):245-53.
  262. Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J; ADVANCE Collaborative Group. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. J Hypertens 2010;28(6):1141-9.
  263. Norman PE, Davis WA, Coughlan MT, Forbes JM, Golledge J, Davis TM. Reply. J Vasc Surg 2010;52(2):536. Author reply.
  264. Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population. Pacing Clin Electrophysiol 2010;33(6):696-704.
  265. O'Brien PE, Sawyer SM, Dixon JB. Laparoscopic gastric banding vs lifestyle intervention in severely obese adolescents. JAMA 2010;303(23):2356-7. Author reply.
  266. O'Brien PE, Sawyer SM, Laurie C, Brown WA, Skinner S, Veit F, Paul E, Burton PR, McGrice M, Anderson M, Dixon JB. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA 2010;303(6):519-26.
  267. Odom GL, Banks GB, Schultz BR, Gregorevic P, Chamberlain JS. Preclinical studies for gene therapy of Duchenne muscular dystrophy. J Child Neurol 2010;25(9):1149-57.
  268. Owen N, Healy GN, Matthews CE, Dunstan DW. Too much sitting: the population health science of sedentary behavior. Exerc Sport Sci Rev 2010;38(3):105-13. Review.
  269. Owen N, Sparling PB, Healy GN, Dunstan DW, Matthews CE. Sedentary behavior: emerging evidence for a new health risk. Mayo Clin Proc 2010;85(12):1138-41. Comment.
  270. Pedersen BK, Febbraio MA. Diabetes: Treatment of diabetes mellitus: new tricks by an old player. Nat Rev Endocrinol 2010;6(9):482-3. Review.
  271. Penfold SA, Coughlan MT, Patel SK, Srivastava PM, Sourris KC, Steer D, Webster DE, Thomas MC, MacIsaac RJ, Jerums G, Burrell LM, Cooper ME, Forbes JM. Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy. Kidney Int 2010;78(3):287-95.
  272. Peter K. Proteomics unravels platelet function. Blood 2010;115(20):4008-9. Editorial.
  273. Peter K, Lip GY. Changing the scope of preventative and therapeutic approaches in atherothrombosis. Thromb Haemost 2010;103(3):487-8. Editorial.
  274. Peter K, Lip GY. Thrombosis and cardiovascular disease: exciting perspectives in cardiovascular prevention and therapy. Thromb Haemost 2010;103(5):875-6. Editorial.
  275. Pfluger HB, Maeder MT, Lagerche A, Taylor AJ. One- and two-dimensional estimation of right and left ventricular size and function-comparison with cardiac magnetic resonance imaging volumetric analysis. Heart Lung Circ 2010;19(9):541-8.
  276. Pham Y, Tu Y, Wu T, Allen TJ, Calkin AC, Watson AM, Li J, Jandeleit-Dahm KA, Toh BH, Cao Z, Cooper ME, Chai Z. Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis. Diabetologia 2010;53(1):170-9.
  277. Phrommintikul A, Abdel-Aty H, Schulz-Menger J, Friedrich MG, Taylor AJ. Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging. Eur J Radiol 2010;74(3):e12-7.
  278. Pirola L. A special BioFactors issue dedicated to resveratrol. Biofactors 2010;36(5):329-30. Editorial.
  279. Pirola L, Balcerczyk A, Okabe J, El-Osta A. Epigenetic phenomena linked to diabetic complications. Nat Rev Endocrinol 2010;6(12):665-75. Review.
  280. Prato SD, LaSalle J, Matthaei S, Bailey CJ; Global Partnership for Effective Diabetes Management. Tailoring treatment to the individual in Type 2 diabetes practical guidance from the Global Partnership for Effective Diabetes Management. Int J Clin Pract 2010;64(3):295-304.
  281. Prior LJ, Eikelis N, Armitage JA, Davern PJ, Burke SL, Montani JP, Barzel B, Head GA. Exposure to a high-fat diet alters leptin sensitivity and elevates renal sympathetic nerve activity and arterial pressure in rabbits. Hypertension 2010;55(4):862-8.
  282. Prior MJ, Foletta VC, Jowett JB, Segal DH, Carless MA, Curran JE, Dyer TD, Moses EK, McAinch AJ, Konstantopoulos N, Bozaoglu K, Collier GR, Cameron-Smith D, Blangero J, Walder KR. The characterization of Abelson helper integration site-1 in skeletal muscle and its links to the metabolic syndrome. Metabolism 2010;59(7):1057-64.
  283. Reutens AT. Diabetes: Individualized therapy for diabetes mellitus--just a promise? Nat Rev Endocrinol 2010;6(8):426-7. Review.
  284. Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, Hevener AL. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab 2010;298(2):E304-19.
  285. Ronaldson KJ, Taylor AJ, Fitzgerald PB, Topliss DJ, Elsik M, McNeil JJ. Diagnostic characteristics of clozapine-induced myocarditis identified by an analysis of 38 cases and 47 controls. J Clin Psychiatry 2010;71(8):976-81.
  286. Rosso R, Kistler PM. Focal atrial tachycardia. Heart 2010;96(3):181-5. Review.
  287. Rosso R, Kistler PM. Sinus rhythm with isolated pulmonary vein fibrillation. Heart 2010;96(4):322.
  288. Rosso R, Sparks PB, Morton JB, Kistler PM, Vohra JK, Halloran K, Medi C, Kalman JM. Vagal paroxysmal atrial fibrillation: prevalence and ablation outcome in patients without structural heart disease. J Cardiovasc Electrophysiol 2010;21(5):489-93.
  289. Rostambeigi N, Shaw JE, Atkins RC, Ghanbarian A, Cameron AJ, Forbes A, Momenan A, Hadaegh F, Mirmiran P, Zimmet PZ, Azizi F, Tonkin AM. Waist circumference has heterogeneous impact on development of diabetes in different populations: longitudinal comparative study between Australia and Iran. Diabetes Res Clin Pract 2010;88(1):117-24.
  290. Rumbold AR, Bailie RS, Si D, Dowden MC, Kennedy CM, Cox RJ, O'Donoghue L, Liddle HE, Kwedza RK, Thompson SC, Burke HP, Brown AD, Weeramanthri T, Connors CM. Assessing the quality of maternal health care in Indigenous primary care services. Med J Aust 2010;192(10):597-8. Letter.
  291. Russell M, Williams M, May E, Stewart S. The conundrum of detecting stable angina pectoris in the community setting. Nat Rev Cardiol 2010;7(2):106-13.
  292. Ruta LA, Dickinson H, Thomas MC, Denton KM, Anderson WP, Kett MM. High-salt diet reveals the hypertensive and renal effects of reduced nephron endowment. Am J Physiol Renal Physiol 2010;298(6):F1384-92.
  293. Sallinen R, Kaunisto MA, Forsblom C, Thomas M, Fagerudd J, Pettersson-Fernholm K, Groop PH, Wessman M; Finnish Diabetic Nephropathy Study Group. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension. Ann Med 2010;42(4):296-304.
  294. Schlaich MP, Grassi G. Sympathoexcitation in calcineurin inhibitor-induced hypertension: villain or innocent bystander? J Hypertens 2010;28(9):1809-10. Editorial.
  295. Schlaich MP, Krum H, Esler MD. New therapeutic approaches to resistant hypertension. Curr Hypertens Rep 2010;12(4):296-302. Review.
  296. Schlaich MP, Krum H, Sobotka PA. Renal sympathetic nerve ablation: the new frontier in the treatment of hypertension. Curr Hypertens Rep 2010;12(1):39-46. Review.
  297. Seach KA, Dharmage SC, Lowe AJ, Dixon JB. Delayed introduction of solid feeding reduces child overweight and obesity at 10 years. Int J Obes 2010;34(10):1475-9.
  298. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(1):4-14.
  299. Shi F, Leckie C, MacIntyre G, Haviv I, Boussioutas A, Kowalczyk A. A bi-ordering approach to linking gene expression with clinical annotations in gastric cancer. BMC Bioinformatics 2010;11:477.
  300. Si D, Bailie R, Dowden M, Kennedy C, Cox R, O'Donoghue L, Liddle H, Kwedza R, Connors C, Thompson S, Burke H, Brown A, Weeramanthri T. Assessing quality of diabetes care and its variation in Aboriginal community health centres in Australia. Diabetes Metab Res Rev 2010;26(6):464-73.
  301. Siebel AL, Fernandez AZ, El-Osta A. Glycemic memory associated epigenetic changes. Biochem Pharmacol 2010;80(12):1853-9. Review.
  302. Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract 2010;87(2):261-6.
  303. Skilton MR. Parity and risk of stroke: fetal origins of adult disease? Neurology 2010;74(18):1408-9. Editorial.
  304. Skilton MR, Bonnet F, Begg LM, Juonala M, Kähönen M, Lehtimäki T, Viikari JS, Raitakari OT. Childbearing, child-rearing, cardiovascular risk factors, and progression of carotid intima-media thickness. The Cardiovascular Risk in Young Finns Study. Stroke 2010;41(7):1332-7.
  305. Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the Heart of Soweto Study. Eur Heart J 2010;31(6):719-27.
  306. Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart 2010;96(23):1878-82.
  307. Snowdon RL, Balasubramaniam R, Teh AW, Haqqani HM, Medi C, Rosso R, Vohra JK, Kistler PM, Morton JB, Sparks PB, Kalman JM. Linear ablation of right atrial free wall flutter: demonstration of bidirectional conduction block as an endpoint associated with long-term success. J Cardiovasc Electrophysiol 2010;21(5):526-31.
  308. Soro-Paavonen A, Zhang WZ, Venardos K, Coughlan MT, Harris E, Tong DC, Brasacchio D, Paavonen K, Chin-Dusting J, Cooper ME, Kaye D, Thomas MC, Forbes JM. Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase. J Hypertens 2010;28(4):780-8.
  309. Sourris KC, Harcourt BE, Penfold SA, Yap FY, Morley AL, Morgan PE, Davies MJ, Baker ST, Jerums G, Forbes JM. Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy. Exp Diabetes Res 2010;974681.
  310. Sourris KC, Morley AL, Koitka A, Samuel P, Coughlan MT, Penfold SA, Thomas MC, Bierhaus A, Nawroth PP, Yamamoto H, Allen TJ, Walther T, Hussain T, Cooper ME, Forbes JM. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia 2010;53(11):2442-51.
  311. Sprung CN, Vasireddy RS, Karagiannis TC, Loveridge SJ, Martin RF, McKay MJ. Methylproamine protects against ionizing radiation by preventing DNA double-strand breaks. Mutat Res 2010;692(1-2):49-52.
  312. Steele P, Strange G, Wlodarczyk J, Dalton B, Stewart S, Gabbay E, Keogh A. Hemodynamics in pulmonary arterial hypertension (PAH): do they explain long-term clinical outcomes with PAH-specific therapy? BMC Cardiovasc Disord 2010;10:9.
  313. Stevenson IH, Roberts-Thomson KC, Kistler PM, Edwards GA, Spence S, Sanders P, Kalman JM. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm 2010;7(9):1263-70.
  314. Stevenson WS, Hyland CD, Zhang JG, Morgan PO, Willson TA, Gill A, Hilton AA, Viney EM, Bahlo M, Masters SL, Hennebry S, Richardson SJ, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS. Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice. Proc Natl Acad Sci USA 2010;107(38):16625-30.
  315. Stewart JE, Feinle-Bisset C, Golding M, Delahunty C, Clifton PM, Keast RS. Oral sensitivity to fatty acids, food consumption and BMI in human subjects. Br J Nutr 2010;104(1):145-52.
  316. Stewart JM, Sanson-Fisher RW, Eades SJ, Mealing NM. Strategies for increasing high-quality intervention research in Aboriginal and Torres Strait Islander health: views of leading researchers. Med J Aust 2010;192(10):612-5.
  317. Stewart S. Heart failure management - a team based approach. Aust Fam Physician 2010;39(12):894-6.
  318. Stewart S, Brown A. Time to get anxious about the broken hearted? Int J Cardiol 2010;145(2):216-7. Editorial.
  319. Stewart S, Ekman I, Ekman T, Odén A, Rosengren A. Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 2010;3(6):573-80.
  320. Straub A, Smolich J, d'Udekem Y, Brizard C, Peter K, Horton S. Activation of platelets in young infants during cardiopulmonary bypass. Thromb Haemost 2010;103(2):466-9.
  321. Straznicky N, Grassi G, Esler M, Lambert G, Dixon J, Lambert E, Jordan J, Schlaich M; European Society of Hypertension Working Group on Obesity; Australian, New Zealand Obesity Society. European Society of Hypertension Working Group on Obesity Antihypertensive effects of weight loss: myth or reality? J Hypertens 2010;28(4):637-43. Review.
  322. Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP, Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F, Chopra R, Sari CI, Paul E, Lambert GW. Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes 2010;59(1):71-9.
  323. Straznicky NE, Lambert GW, Lambert EA. Neuroadrenergic dysfunction in obesity: an overview of the effects of weight loss. Curr Opin Lipidol 2010;21(1):21-30. Review.
  324. Study of Environment on Aboriginal Resilience and Child Health Investigators. The Study of Environment on Aboriginal Resilience and Child Health (SEARCH): study protocol. BMC Public Health 2010;10:287. Protocol.
  325. Sviridov D. Frontiers in research series: Physiological and pathological functions of high-density lipoprotein. Introduction. Clin Exp Pharmacol Physiol 2010;37(7):700-2. Editorial.
  326. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376(9756):1903-9.
  327. Tan AL, Sourris KC, Harcourt BE, Thallas-Bonke V, Penfold S, Andrikopoulos S, Thomas MC, O'Brien RC, Bierhaus A, Cooper ME, Forbes JM, Coughlan MT. Disparate effects on renal and oxidative parameters following RAGE deletion, AGE accumulation inhibition, or dietary AGE control in experimental diabetic nephropathy. Am J Physiol Renal Physiol 2010;298(3):F763-70.
  328. Tan MA, Fuller M, Zabidi-Hussin ZA, Hopwood JJ, Meikle PJ. Biochemical profiling to predict disease severity in metachromatic leukodystrophy. Mol Genet Metab 2010;99(2):142-8.
  329. Tandy S, Chung RW, Kamili A, Wat E, Weir JM, Meikle PJ, Cohn JS. Hydrogenated phosphatidylcholine supplementation reduces hepatic lipid levels in mice fed a high-fat diet. Atherosclerosis 2010;213(1):142-7.
  330. Tang MM, Mah LJ, Vasireddy RS, Georgiadis GT, El-Osta A, Royce SG, Karagiannis TC. Quantitation of gammaH2AX foci in tissue samples. J Vis Exp 2010;(40):pii:2063.
  331. Tapp RJ, O'Neil A, Shaw JE, Zimmet PZ, Oldenburg BF; AusDiab Study Group. Is there a link between components of health-related functioning and incident impaired glucose metabolism and Type 2 diabetes? The Australian Diabetes Obesity and Lifestyle (AusDiab) study. Diabetes Care 2010;33(4):757-62.
  332. Taylor AJ, Elsik M, Broughton A, Cherayath J, Leet A, Wong C, Iles L, Butler M, Pfluger H. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy. Europace 2010;12(5):708-13.
  333. Taylor AJ, Vaddadi G, Pfluger H, Butler M, Bergin P, Leet A, Richardson M, Cherayath J, Iles L, Kaye DM. Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection. Eur J Heart Fail 2010;12(1):45-51.
  334. Teh AW, Kalman JM, Kistler PM, Lee G, Sutherland F, Morton JB, Vohra JK, Sparks PB. Prevalence of fractionated electrograms in the coronary sinus: comparison between patients with persistent or paroxysmal atrial fibrillation and a control population. Heart Rhythm 2010;7(9):1200-4.
  335. Teh AW, Kalman JM, Medi C, Rosso R, Balasubramaniam R, Lee G, Halloran K, Sparks PB, Morton JB, Vohra JK, Kistler PM. Long-term outcome following successful catheter ablation of atrial tachycardia originating from the pulmonary veins: absence of late atrial fibrillation. J Cardiovasc Electrophysiol 2010;21(7):747-50.
  336. Teichtahl AJ, Wluka AE, Wang Y, Jones G, Ding C, Cicuttini FM. Identification of early knee osteoarthritis - a new horizon. Curr Rheumatol Rev 2010;6(4):251-6. Review.
  337. Thallas-Bonke V, Coughlan MT, Bach LA, Cooper ME, Forbes JM. Preservation of kidney function with combined inhibition of NADPH oxidase and angiotensin-converting enzyme in diabetic nephropathy. Am J Nephrol 2010;32(1):73-82.
  338. Thomas MC, Cooper ME. Into the light? Diabetic nephropathy and vitamin D. Lancet 2010;376(9752):1521-2. Comment.
  339. Thomas MC, Pickering RJ, Tsorotes D, Koitka A, Sheehy K, Bernardi S, Toffoli B, Nguyen-Huu TP, Head GA, Fu Y, Chin-Dusting J, Cooper ME, Tikellis C. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ Res 2010;107(7):888-97.
  340. Thomson RL, Buckley JD, Lim SS, Noakes M, Clifton PM, Norman RJ, Brinkworth GD. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril 2010;94(5):1812-6.
  341. Thorp AA, Healy GN, Owen N, Salmon J, Ball K, Shaw JE, Zimmet PZ, Dunstan DW. Deleterious associations of sitting time and television viewing time with cardiometabolic risk biomarkers: Australian Diabetes, Obesity and Lifestyle (AusDiab) study 2004-2005. Diabetes Care 2010;33(2):327-34.
  342. Thrift AG. Case-control studies: the importance of design and conduct. Neuroepidemiology 2010;34(4):264-6.
  343. Thrift AG. Design and methods of population surveys. Neuroepidemiology 2010;34(4):267-9.
  344. Thrift AG. Systematic review of observational studies. Neuroepidemiology 2010;34(4):262-3.
  345. Thrift AG, Kim J. Missed opportunities to prevent stroke recurrence. Clin Exp Pharmacol Physiol 2010;37(8):773-4. Editorial.
  346. Thrift AG, Srikanth V, Evans RG. How generalisable is INTERSTROKE? Lancet 2010;376(9752):1538-9. Letter.
  347. Thrift AG, Srikanth V, Fitzgerald SM, Kalyanram K, Kartik K, Hoppe CC, Walker KZ, Evans RG. Potential roles of high salt intake and maternal malnutrition in the development of hypertension in disadvantaged populations. Clin Exp Pharmacol Physiol 2010;37(2):e78-90.
  348. Toh B-H, Tu Y, Cao Z, Cooper ME, Chai Z. Role of cell division autoantigen 1 (CDA1) in cell proliferation and fibrosis. Genes 2010;1(3):335-48. Review.
  349. Tonna S, El-Osta A, Cooper ME, Tikellis C. Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms. Nat Rev Nephrol 2010;6(6):332-41. Review.
  350. Tyssen D, Henderson SA, Johnson A, Sterjovski J, Moore K, La J, Zanin M, Sonza S, Karellas P, Giannis MP, Krippner G, Wesselingh S, McCarthy T, Gorry PR, Ramsland PA, Cone R, Paull JR, Lewis GR, Tachedjian G. Structure activity relationship of dendrimer microbicides with dual action antiviral activity. PLoS One 2010;5(8):e12309.
  351. Urquhart DM, Hanna FS, Brennan SL, Wluka AE, Leder K, Cameron PA, Graves SE, Cicuttini FM. Incidence and risk factors for deep surgical site infection after primary total hip arthroplasty: a systematic review. J Arthroplasty 2010;25(8):1216-22.e1-3. Review.
  352. Vaddadi G, Corcoran SJ, Esler M. Management strategies for recurrent vasovagal syncope. Intern Med J 2010;40(8):554-60. Review.
  353. Vaddadi G, Esler MD, Dawood T, Lambert E. Persistence of muscle sympathetic nerve activity during vasovagal syncope. Eur Heart J 2010;31(16):2027-33.
  354. van Uffelen JG, Wong J, Chau JY, van der Ploeg HP, Riphagen I, Gilson ND, Burton NW, Healy GN, Thorp AA, Clark BK, Gardiner PA, Dunstan DW, Bauman A, Owen N, Brown WJ. Occupational sitting and health risks: a systematic review. Am J Prev Med 2010;39(4):379-88. Review.
  355. Vasireddy RS, Karagiannis TC, El-Osta A. gamma-radiation-induced gammaH2AX formation occurs preferentially in actively transcribing euchromatic loci. Cell Mol Life Sci 2010;67(2):291-4.
  356. Vasireddy RS, Tang MM, Mah LJ, Georgiadis GT, El-Osta A, Karagiannis TC. Evaluation of the spatial distribution of gammaH2AX following ionizing radiation. J Vis Exp 2010;(42):pii:2203.
  357. Walker KZ, O'Dea K, Gomez M, Girgis S, Colagiuri R. Diet and exercise in the prevention of diabetes. J Hum Nutr Diet 2010;23(4):344-52. Review.
  358. Walker KZ, Woods J, Ross J, Hechtman R. Yoghurt and dairy snacks presented for sale to an Australian consumer: are they becoming less healthy? Public Health Nutr 2010;13(7):1036-41.
  359. Walls HL, Wolfe R, Haby MM, Magliano DJ, de Courten M, Reid CM, McNeil JJ, Shaw J, Peeters A. Trends in BMI of urban Australian adults, 1980-2000. Public Health Nutr 2010;13(5):631-8.
  360. Wand APF, Eades SJ, Corr MJ. Considering culture in the psychiatric assessment of Aboriginal and Torres Strait Islander peoples. Adv Ment Health 2010:9(1);36-48.
  361. Wang B, Herman-Edelstein M, Koh P, Burns W, Jandeleit-Dahm K, Watson A, Saleem M, Goodall GJ, Twigg SM, Cooper ME, Kantharidis P. E-cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth factor-. Diabetes 2010;59(7):1794-802.
  362. Wang X, McLennan SV, Allen TJ, Twigg SM. Regulation of pro-inflammatory and pro-fibrotic factors by CCN2/CTGF in H9c2 cardiomyocytes. J Cell Commun Signal 2010;4(1):15-23.
  363. Warner TD, Armstrong PC, Curzen NP, Mitchell JA. Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists? Heart 2010;96(21):1693-4. Comment.
  364. Watson AM, Li J, Schumacher C, de Gasparo M, Feng B, Thomas MC, Allen TJ, Cooper ME, Jandeleit-Dahm KA. The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice. Diabetologia 2010;53(1):192-203.
  365. Weisinger RS, Armitage JA, Chen N, Begg DP, Mathai ML, Jayasooriya AP, Sinclair AJ, Weisinger HS. Sodium appetite in adult rats following ω-3 polyunsaturated fatty acid deficiency in early development. Appetite 2010;55(3):393-7.
  366. White H, Walsh W, Brown A, Riddell T, Tonkin A, Jeremy R, Brieger D, Zeitz C, Kritharides L. Rheumatic heart disease in indigenous populations. Heart Lung Circ 2010;19(5-6):273-81. Review.
  367. White SL, Polkinghorne KR, Atkins RC, Chadban SJ. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study. Am J Kidney Dis 2010;55(4):660-70.
  368. Wijndaele K, Healy GN, Dunstan DW, Barnett AG, Salmon J, Shaw JE, Zimmet PZ, Owen N. Increased cardiometabolic risk is associated with increased TV viewing time. Med Sci Sports Exerc 2010;42(8):1511-8.
  369. Wilkinson-Berka JL, Heine R, Tan G, Cooper ME, Hatzopoulos KM, Fletcher EL, Binger KJ, Campbell DJ, Miller AG. RILLKKMPSV influences the vasculature, neurons and glia, and (pro)renin receptor expression in the retina. Hypertension 2010;55(6):1454-60.
  370. Williams ED, Tapp RJ, Magliano DJ, Shaw JE, Zimmet PZ, Oldenburg BF. Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab). Diabetologia 2010;53(12):2538-45.
  371. Williamson A, Redman S, Dadds M, Daniels J, D'Este C, Raphael B, Eades S, Skinner T. Acceptability of an emotional and behavioural screening tool for children in Aboriginal Community Controlled Health Services in urban NSW. Aust N Z J Psychiatry 2010;44(10):894-900.
  372. Williamson AB, Raphael B, Redman S, Daniels J, Eades SJ, Mayers N. Emerging themes in Aboriginal child and adolescent mental health: findings from a qualitative study in Sydney, New South Wales. Med J Aust 2010;192(10):603-5.
  373. Wong G, Leckie C, Gorringe KL, Haviv I, Campbell IG, Kowalczyk A. Exploiting sequence similarity to validate the sensitivity of SNP arrays in detecting fine-scaled copy number variations. Bioinformatics 2010;26(8):1007-14.
  374. Wong SE, Winbanks CE, Samuel CS, Hewitson TD. Lectin histochemistry for light and electron microscopy. Methods Mol Biol 2010;611:103-14.
  375. Woodcock EA, Grubb DR, Iliades P. Potential treatment of cardiac hypertrophy and heart failure by inhibiting the sarcolemmal binding of phospholipase Cbeta1b. Curr Drug Targets 2010;11(8):1032-40. Review.
  376. Woollard KJ, Chin-Dusting J. P-selectin antagonism in inflammatory disease. Curr Pharm Des 2010;16(37):4113-8. Review.
  377. Woollard KJ, de Courten MPJ, Sourris KC, Drew BG, Henstridge DC, Kingwell B, Cooper M, Howlett KF, Forbes JM, de Couten B. The association between soluble P-selectin and insulin sensitivity in healthy humans. J Clin Metab Diabetes 2010;1(1):19-26.
    Wycherley TP, Brinkworth GD, Keogh JB, Noakes M, Buckley JD, Clifton PM. Long-term effects of weight loss with a very low carbohydrate and low fat diet on vascular function in overweight and obese patients. J Intern Med 2010;267(5):452-61.
  378. Xiao H, Zhang YY, Du XJ, Lu ZZ. Developmental changes in the geometry, function and responsiveness of the mouse heart to -adrenergic stimulation as determined by high-resolution echocardiography. Clin Exp Pharmacol Physiol 2010;37(8):826-32.
  379. Xu Q, Chakravorty A, Bathgate RA, Dart AM, Du XJ. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats. Hypertension 2010;55(5):1260-6.
  380. Yang KC, Foeger NC, Marionneau C, Jay PY, McMullen JR, Nerbonne JM. Homeostatic regulation of electrical excitability in physiological cardiac hypertrophy. J Physiol 2010;588(Pt 24):5015-32.
  381. Yang SN, Burch ML, Tannock LR, Evanko S, Osman N, Little PJ. Transforming growth factor- regulation of proteoglycan synthesis in vascular smooth muscle: contribution to lipid binding and accelerated atherosclerosis in diabetes. J Diabetes 2010;2(4):233-42. Review.
  382. Yau JW, Kawasaki R, Islam FM, Shaw J, Zimmet P, Wang JJ, Wong TY. Retinal fractal dimension is increased in persons with diabetes but not impaired glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Diabetologia 2010;53(9):2042-5.
  383. Ying SQ, Xiang MX, Fang L, Wang JA. Temporal changes in circulating P-selectin, plasminogen activator inhibitor-1, magnesium, and creatine kinase after percutaneous coronary intervention. J Zhejiang Univ Sci B 2010;11(8):575-82.
  384. Zhang L, Qiao Q, Tuomilehto J, Janus ED, Lam TH, Ramachandran A, Mohan V, Stehouwer CD, Dong Y, Nakagami T, Onat A, Söderberg S; DECODE/DECODA Study Group. Distinct ethnic differences in lipid profiles across glucose categories. J Clin Endocrinol Metab 2010;95(4):1793-801.
  385. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, Nichols G. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87(3):293-301.
  386. Zhou XH, Qiao Q, Zethelius B, Pyörälä K, Söderberg S, Pajak A, Stehouwer CD, Heine RJ, Jousilahti P, Ruotolo G, Nilsson PM, Calori G, Tuomilehto J; DECODE Study Group. Diabetes, prediabetes and cancer mortality. Diabetologia 2010;53(9):1867-76.


  1. Davidson P, Driscoll A, Huang N, Aho Z, Atherton J, Krum H, Sindone A, Stewart S. Multidisciplinary Care for People with Chronic Heart Failure: Principles and Recommendations for Best Practice. 2010. ISBN 97819211226908. National Heart Foundation of Australia.
  2. Dietel M, Gagner M, Dixon JB, Himpens J, Madan AK. Handbook of Obesity Surgery: Current Concepts and Therapy of Morbid Obesity and Related Diseases. 2010. ISBN 9780968442654. FD-Communications, Toronto, Canada.
  3. Thomas MC, Forbes J. Maillard Reaction: Interface between Aging, Nutrition and Metabolism. 2010. ISBN 9781849730792. Royal Society of Chemistry, Cambridge, England.

Book chapters

  1. Candido R, Cooper M, Jandeleit-Dahm K. The pathophysiology of macrovascular complications, including atherosclerosis in diabetes. In: Holt RIG, Goldstein B, Flvbjerg A, Cockram C (eds), Textbook of Diabetes, 4th edition, Wiley-Blackwell, Chichester, UK. 2010; pp637-56.
  2. Deitel M. Dixon JB. Co-morbidities of morbid obesity and determination of optimal weight. In: Dietel M, Gagner M, Dixon JB, Himpens J, Madan AK (eds), Handbook of Obesity Surgery: Current Concepts and Therapy of Morbid Obesity and Related Diseases, FD-Communications, Toronto, Canada. 2010.
  3. Deitel M, Field SK, Mehta A, Dixon JB. Obstructive sleep apnea in the obese. In: Dietel M, Gagner M, Dixon JB, Himpens J, Madan AK (eds), Handbook of Obesity Surgery: Current Concepts and Therapy of Morbid Obesity and Related Diseases, FD-Communications, Toronto, Canada. 2010.
  4. Jacques J, Dixon JB. Prevention of vitamin, mineral and nutritional deficiencies. In: Dietel M, Gagner M, Dixon JB, Himpens J, Madan AK (eds), Handbook of Obesity Surgery: Current Concepts and Therapy of Morbid Obesity and Related Diseases, FD-Communications, Toronto, Canada. 2010.
  5. Jandeleit-Dahm KAM, Thomas MC, Giunti S. Can biomarkers predict cardiovascular disease in diabetes? In: Yagil Y (ed), International Conference on Early Disease Detection and Prevention - EDDP, Medimond International Proceedings, Bologna, Italy. 2010; pp9-14.
  6. le Roux CW, Dixon JB. Metabolic syndrome and Type 2 diabetes: GLP-1 and other incretins. In: Dietel M, Gagner M, Dixon JB, Himpens J, Madan AK (eds), Handbook of Obesity Surgery: Current Concepts and Therapy of Morbid Obesity and Related Diseases, FD-Communications, Toronto, Canada. 2010.
  7. Masuo K, Lambert GW, Esler MD. The role of sympathetic nerve activity in renal injury. In: Fuchs S, Auer M (eds), Biochemistry and Histochemistry Research Developments, Nova Science Publishers, New York, USA. 2010; Chapter 4, pp100-17.
  8. Penfold SA, Sourris KC, Coughlan MT, Tan AL, Kaye DM, Cooper ME, Forbes JM. The pathogenic potential of different sized AGE modified molecules via RAGE signalling pathways. Thomas MC, Forbes J (eds), Maillard Reaction: Interface between Aging, Nutrition and Metabolism, Royal Society of Chemistry, Cambridge, England. 2010; pp21-30.
  9. Siebel AL, Fernandez AZ, El-Osta A. Glycemic memory and epigenetic changes. In: Maulik N, Maulik G (eds), Nutrition, Epigenetic Mechanisms, and Human Disease, Taylor & Francis Group-CRC Press, Boca Raton, USA. 2010; Chapter 9, pp215-28.
  10. Sourris KC, Forbes JM. The renin-angiotensin system and advanced glycation end-products in diabetic nephropathy. How important are these pathways as therapeutic targets? Thomas MC, Forbes J (eds), Maillard Reaction: Interface between Aging, Nutrition and Metabolism, Royal Society of Chemistry, Cambridge, England. 2010; pp133-6.
  11. Thrift AG, Gall SL, Brown AD. Burden of cardiovascular diseases among Aboriginal and Torres Strait Islander peoples: mortality, hospitalization and risk factors. In: Preedy VR, Watson RR (eds), Handbook of Disease Burdens and Quality of Life Measures, Springer, New York, USA. 2010; Chapter 264, pp919-31.
  12. Thrift AG, Srikanth VK. Stroke: epidemiology and pathology. In: Fillit HM, Rockwood K, Woodhouse K (eds), Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 7th edition, Elsevier-Saunders, Philadelphia, USA. 2010; Chapter 61, pp478-83.
  13. Watson AMD, Soro-Paavonen A, Jandeleit-Dahm KA. AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes. In: Dauphinee SM, Karsan A (eds), Endothelial Dysfunction and Inflammation, Progress in Inflammation Research series, Springer-Birkhauser Publishing, Basel, Switzerland. 2010; pp161-74.
  14. Watson A, Thomas MC, Koh P, Figorala JL, Rahbar S, Jandeleit-Dahm K. Attenuation of diabetes-associated atherosclerosis with LR-90, a novel inhibitor of AGE formation. In: Thomas MC, Forbes J (eds), Maillard Reaction: Interface between Aging, Nutrition and Metabolism, Royal Society of Chemistry, Cambridge, England. 2010; pp137-43.
  15. Winbanks CE, Gregorevic P. Combinatorial gene therapy strategies for treating muscular dystrophies. In: Duan D (ed), Muscle Gene Therapy, Springer, New York, USA. 2010; Chapter 8, pp117-40.

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more